Silver Book Fact

Following the current path, the lung cancer incidence rate will increase by 34% between 2003 and 2023. If an alternative path is taken, there will be 18.4% (92,000) fewer lung cancer cases in 2023.

DeVol R, Bedroussian A, Charuworn A, Chatterjee A, et al. An Unhealthy America: The economic burden of chronic disease. The Milken Institute; 2007. https://assets1b.milkeninstitute.org/assets/Publication/ResearchReport/PDF/chronic_disease_report.pdf

Reference

Title
An Unhealthy America: The economic burden of chronic disease
Publisher
The Milken Institute
Publication Date
2007
Authors
DeVol R, Bedroussian A, Charuworn A, Chatterjee A, et al.
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • According to the Pharmaceutical Research and Manufacturers of America, a medicine in development that is a monoclonal antibody, targets the epidermal growth factor receptor. Because cancer cells can become…  
  • A prostate cancer vaccine, sipleucel-T immunotherapy, in men with metastatic castration-resistant prostate cancer, reduced the risk of death by 22 percent compared to placebo, and represented a 4.2 month improvement in…  
  • Baseline lung cancer screening would lead to more than 130,000 additional survivors in 2012.  
  • Cancer mortality declined more than 2% in 2003, a continuation of the decline that began in 1990.  
  • The overall five-year survival rate for men with prostate cancer is 99 percent—up from 43 percent in 1975.